Corbeil-Essonnes

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia2 trials
• Familial hypercholesterolaemia1 trial
• Metastatic breast cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Completed2 trials

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Active, not recruiting

  Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

  NCT06092879· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

  NCT05697146· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

  NCT07839858· Novartis Pharmaceuticals· Source

• Completed

  Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

  NCT01784068· Phase 2· Novartis Pharmaceuticals· Source